Presented Joint Research Results with Astellas Pharma at the 24th Annual Meeting of the Japanese Society for Regenerative Medicine
At the luncheon seminar of the 24th Annual Meeting of the Japanese Society for Regenerative Medicine, held from March 20 to 22, we will present the joint research results of Astellas Pharma Inc. and Epistra.
The seminar will introduce the outcomes of a stem cell culture condition optimization project combining the automated experiment robot “Mahoro” and our AI “Epistra Accelerate.”
Key achievements through the use of AI include:
- Significant improvement in differentiation efficiency compared to conventional methods
- Simultaneous achievement of “QbD” (design space) alongside condition optimization
Seminar Details
- Venue: Pacifico Yokohama North 4F G416+G417
- Chair: Dr. Yoji Sato (National Institute of Health Sciences)
Related Articles
Won Grand Prix in the 7th IP BASE AWARD Startup Category Hosted by the Japan Patent Office
On March 3, 2026, Epistra Inc. won the Grand Prix in the startup category at the '7th IP BASE AWARD' ceremony hosted by the Japan Patent Office.
Jikkenigaku Special Issue 'AI and Data-Driven Drug Discovery Research' Published — CTO Tsuzuki Authors Chapter on AI-Driven Drug Target Discovery
In 'Jikkenigaku Special Issue: AI and Data-Driven Drug Discovery Research' published by Yodosha, our CTO Taku Tsuzuki authored a chapter on AI-driven knowledge mining for drug target discovery.
Speaking Engagement: Delivered Keynote at the 10th Cell Manufacturing Kotozukuri Symposium
On March 4, 2026, CEO Yosuke Ozawa delivered a keynote speech on optimizing cell manufacturing processes using AI and robotics at the '10th Cell Manufacturing Kotozukuri Symposium' hosted by Osaka University.